ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE000KJPDY61
Stock Name / FundiShares World Equity High Income UCITS ETF USD Inc
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWINC(GBP) LSE
ETF TickerWINC.AS(USD) AS
ETF TickerWINC(USD) Euronext Amsterdam

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares World Equity High Income UCITS ETF USD Inc LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-12-26 (Friday)841LLY holding increased by 810USD 906,388LLY holding increased by 873002USD 906,388810USD 873,002 USD 1077.75 USD 1076.97
2025-12-26 (Friday)31LLY holding increased by 810USD 33,410LLY holding increased by 873002USD 33,410810USD 873,002 USD 1077.75 USD 1076.97
2025-12-24 (Wednesday)841LLY holding increased by 810USD 905,740LLY holding increased by 872519USD 905,740810USD 872,519 USD 1076.98 USD 1071.65
2025-12-24 (Wednesday)31LLY holding increased by 810USD 33,386LLY holding increased by 872519USD 33,386810USD 872,519 USD 1076.98 USD 1071.65
2025-12-23 (Tuesday)841LLY holding increased by 810USD 901,249LLY holding increased by 867878USD 901,249810USD 867,878 USD 1071.64 USD 1076.48
2025-12-23 (Tuesday)31LLY holding increased by 810USD 33,221LLY holding increased by 867878USD 33,221810USD 867,878 USD 1071.64 USD 1076.48
2025-12-22 (Monday)946LLY holding increased by 915USD 1,018,350LLY holding increased by 985135USD 1,018,350915USD 985,135 USD 1076.48 USD 1071.45
2025-12-22 (Monday)31LLY holding increased by 915USD 33,371LLY holding increased by 985135USD 33,371915USD 985,135 USD 1076.48 USD 1071.45
2025-12-19 (Friday)937LLY holding increased by 906USD 1,003,939LLY holding increased by 971176USD 1,003,939906USD 971,176 USD 1071.44 USD 1056.87
2025-12-19 (Friday)31LLY holding increased by 906USD 33,215LLY holding increased by 971176USD 33,215906USD 971,176 USD 1071.44 USD 1056.87
2025-12-18 (Thursday)937LLY holding increased by 906USD 990,297LLY holding increased by 958002USD 990,297906USD 958,002 USD 1056.88 USD 1041.77
2025-12-18 (Thursday)31LLY holding increased by 906USD 32,763LLY holding increased by 958002USD 32,763906USD 958,002 USD 1056.88 USD 1041.77
2025-12-17 (Wednesday)937LLY holding increased by 906USD 976,157LLY holding increased by 943474USD 976,157906USD 943,474 USD 1041.79 USD 1054.29
2025-12-17 (Wednesday)31LLY holding increased by 906USD 32,295LLY holding increased by 943474USD 32,295906USD 943,474 USD 1041.79 USD 1054.29
2025-12-16 (Tuesday)937LLY holding increased by 906USD 987,870LLY holding increased by 954942USD 987,870906USD 954,942 USD 1054.29 USD 1062.19
2025-12-16 (Tuesday)31LLY holding increased by 906USD 32,683LLY holding increased by 954942USD 32,683906USD 954,942 USD 1054.29 USD 1062.19
2025-12-15 (Monday)985LLY holding increased by 954USD 1,046,257LLY holding increased by 1014404USD 1,046,257954USD 1,014,404 USD 1062.19 USD 1027.52
2025-12-15 (Monday)31LLY holding increased by 954USD 32,928LLY holding increased by 1014404USD 32,928954USD 1,014,404 USD 1062.19 USD 1027.52
2025-12-12 (Friday)985LLY holding increased by 954USD 1,012,097LLY holding increased by 980806USD 1,012,097954USD 980,806 USD 1027.51 USD 1009.39
2025-12-12 (Friday)31LLY holding increased by 954USD 31,853LLY holding increased by 980806USD 31,853954USD 980,806 USD 1027.51 USD 1009.39
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE000KJPDY61

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-26BUY8101,081.3901,068.330 1,069.636EUR 866,405 871.56
2025-12-24BUY8101,085.7301,072.710 1,074.012EUR 869,950 870.17
2025-12-24BUY8101,085.7301,072.710 1,074.012EUR 869,950 870.17
2025-12-23BUY8101,088.4801,063.500 1,065.998EUR 863,458 868.80
2025-12-22BUY9151,083.4801,063.000 1,065.048EUR 974,519 867.38
2025-12-19BUY9061,075.3801,059.395 1,060.994EUR 961,260 865.97
2025-12-18BUY9061,076.9901,040.000 1,043.699EUR 945,591 864.65
2025-12-17BUY9061,064.3001,036.420 1,039.208EUR 941,522 863.41
2025-12-16BUY9061,068.2301,036.230 1,039.430EUR 941,724 862.06
2025-12-15BUY9541,065.0001,032.550 1,035.795EUR 988,148 860.64
2025-12-12BUY9541,028.9001,003.500 1,006.040EUR 959,762 859.45
2025-12-11BUY9511,031.561987.000 991.456EUR 942,875 858.37
2025-12-10BUY9511,003.000977.120 979.708EUR 931,702 857.39
2025-12-09BUY9511,012.000979.180 982.462EUR 934,321 856.48
2025-12-08BUY9421,014.200989.000 991.520EUR 934,012 855.44
2025-12-05BUY9361,027.3901,004.000 1,006.339EUR 941,933 854.30
2025-12-04BUY9361,032.6301,007.180 1,009.725EUR 945,103 853.10
2025-12-03BUY9301,051.4781,022.320 1,025.236EUR 953,469 851.74
2025-12-02BUY9301,068.1801,040.360 1,043.142EUR 970,122 850.27
2025-12-01BUY9301,084.1501,055.000 1,057.915EUR 983,861 848.69
2025-11-28BUY9241,098.8701,067.800 1,070.907EUR 989,518 846.94
2025-11-27BUY924 1,104.340* 844.95
2025-11-26BUY9241,111.9901,098.100 1,099.489EUR 1,015,928 842.92
2025-11-26BUY9241,111.9901,098.100 1,099.489EUR 1,015,928 842.92
2025-11-25BUY9241,111.1101,073.250 1,077.036EUR 995,181 840.82
2025-11-24BUY9241,075.7201,049.380 1,052.014EUR 972,061 839.00
2025-11-21BUY9271,066.6501,038.000 1,040.865EUR 964,882 837.23
2025-11-20BUY9271,057.0001,038.250 1,040.125EUR 964,196 835.57
2025-11-19BUY9211,055.5501,026.250 1,029.180EUR 947,875 833.83
2025-11-18BUY9151,040.7241,017.255 1,019.602EUR 932,936 832.22
2025-11-17BUY9091,032.141998.302 1,001.685EUR 910,532 830.66
2025-11-14BUY9091,033.6191,007.785 1,010.368EUR 918,425 829.03
2025-11-13BUY9091,032.9501,010.085 1,012.372EUR 920,246 827.41
2025-11-12BUY9091,022.420990.100 993.332EUR 902,939 825.79
2025-11-11BUY909999.920965.285 968.748EUR 880,592 824.40
2025-11-10BUY769981.990938.830 943.146EUR 725,279 823.17
2025-11-07BUY769932.000900.900 904.010EUR 695,184 822.29
2025-11-06BUY769949.890916.263 919.626EUR 707,192 821.28
2025-11-05BUY760955.410908.230 912.948EUR 693,840 820.36
2025-11-04BUY750915.220883.640 886.798EUR 665,099 819.59
2025-11-03BUY664901.339862.680 866.546EUR 575,386 818.89
2025-10-31BUY664869.910834.950 838.446EUR 556,728 818.49
2025-10-30BUY664853.000812.250 816.325EUR 542,040 818.26
2025-10-29BUY664813.530830.290 828.614EUR 550,200 818.30
2025-10-28BUY664820.100829.460 828.524EUR 550,140 818.28
2025-10-27BUY664826.410826.420 826.419EUR 548,742 818.21
2025-10-24BUY658825.450834.150 833.280EUR 548,298 818.14
2025-10-23BUY658821.040824.700 824.334EUR 542,412 818.11
2025-10-22BUY658812.430815.940 815.589EUR 536,658 818.16
2025-10-21BUY658799.570812.990 811.648EUR 534,064 818.35
2025-10-20BUY654808.960809.410 809.365EUR 529,325 818.44
2025-10-17BUY654802.830804.440 804.279EUR 525,998 818.60
2025-10-16BUY654819.380834.700 833.168EUR 544,892 818.59
2025-10-15SELL-642826.570830.190 829.828EUR -532,750 818.51 Loss of -7,269 on sale
2025-10-03BUY4839.870848.130 847.304EUR 3,389 818.29
2025-10-02BUY10819.850834.460 832.999EUR 8,330 818.27
2025-10-01BUY6825.420833.300 832.512EUR 4,995 818.19
2025-06-11SELL-116808.610820.720 819.509EUR -95,063 820.12 Profit of 71 on sale
2025-06-03BUY78750.780757.000 756.378EUR 58,997 823.39
2025-05-09BUY1734.570762.010 759.266EUR 759 830.11
2025-05-06SELL-49775.120818.420 814.090EUR -39,890 832.60 Profit of 907 on sale
2025-05-05BUY58821.460829.640 828.822EUR 48,072 832.75
2025-05-02BUY58823.620831.530 830.739EUR 48,183 832.87
2025-05-01BUY58794.100850.930 845.247EUR 49,024 833.41
2025-04-30BUY58898.950902.500 902.145EUR 52,324 832.49
2025-04-29BUY58885.200892.470 891.743EUR 51,721 831.74
2025-04-28BUY101877.290882.250 881.754EUR 89,057 831.08
2025-04-25BUY101884.540885.580 885.476EUR 89,433 830.29
2025-04-24BUY101859.730862.250 861.998EUR 87,062 829.85
2025-04-23BUY101829.420846.010 844.351EUR 85,279 829.86
2025-04-22BUY108827.540832.000 831.554EUR 89,808 829.89
2025-04-21BUY7818.020843.910 841.321EUR 5,889 829.74
2025-04-18BUY7 839.956* 829.57
2025-04-17BUY7839.960858.000 856.196EUR 5,993 829.41
2025-04-16BUY7734.900756.300 754.160EUR 5,279 830.96
2025-04-15BUY7757.180765.310 764.497EUR 5,351 832.19
2025-04-09BUY5753.710754.830 754.718EUR 3,774 838.75
2025-04-08SELL-117726.240763.500 759.774EUR -88,894 840.79 Profit of 9,479 on sale
2025-04-04BUY1738.210768.270 765.264EUR 765 844.94
2025-04-01SELL-28805.230820.660 819.117EUR -22,935 846.24 Profit of 759 on sale
2025-03-26BUY10826.760851.410 848.945EUR 8,489 848.11
2025-03-19BUY2837.010842.130 841.618EUR 1,683 848.26
2025-03-14BUY6813.480815.210 815.037EUR 4,890 850.41
2025-03-11BUY29824.060832.350 831.521EUR 24,114 853.29
2025-02-26BUY3915.010922.430 921.688EUR 2,765 839.57
2025-02-18SELL-30857.200862.730 862.177EUR -25,865 829.71 Loss of -974 on sale
2025-02-10BUY4868.880880.000 878.888EUR 3,516 817.90
2025-02-04SELL-27826.070829.040 828.743EUR -22,376 805.79 Loss of -620 on sale
2025-01-27BUY2808.170809.250 809.142EUR 1,618 801.25
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy